Correlation of antitumor effect of recombinant sea snake basic phospholipase A2 to its enzymatic activity

Yong Ju Liang, Xiao Ping Yang, Jian Wen Wei, Li Wu Fu, Xiaoyu Jiang, Shang Wu Chen, Wen Li Yang

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

BACKGROUND & OBJECTIVE:Snake venom phospolipase A2 (PLA(2)), a large family of homologous (14 ku) soluble proteins, exerts diverse pharmacologic activities as well as enzymatic activities. So far, the structure and function of terrestrial snake PLA(2), especially the relationship of its enzymatic and pharmacologic activities have been studied extensively, but the investigation of sea snake PLA(2) are limited. This study was to investigate the in vitro and in vivo antitumor effects of recombinant sea snake basic PLA(2) (rSSBPLA(2)) and its mutants rN48 and rK4 from sea snake Lapemis hardwickii venom, and to explore the influence of 2 residues related with the enzymatic activity on the antitumor effects. METHODS: Site-directed mutagenesis of the 2 conserved residues related with enzymatic activity (His48 mutated to Asn and Asp49 mutated to Lys) was performed. The inhibitory effects of rSSBPLA(2), rN48 and rK49 on proliferation of human myeloid leukemia cell line HL-60, human neuroblastoma cell line SK-N-SH, human gastric cancer cell line MGC-803, and human liver cancer cell line HepG2 were assessed by MTT assay. Their antitumor effects on sarcoma cell line S180 xenograft and EAC ascites cancer model in mice were detected. RESULTS: The relative enzymatic activities of rN48 and rK49 were 0 and 5% of that of rSSBPLA(2). The 50% inhibitory concentration (IC(50)) of rSSBPLA(2) for HL60, SK-N-SH, and MGC-803 cells were (45.28+/-0.09) microg/ml, (57.07+/-0.12) microg/ml, and (69.34+/-0.35) microg/ml, respectively, but it had no inhibitory effect on proliferation of HepG2 cells. rSSBPLA(2) obviously inhibited growth of S180 xenograft in miceû the inhibitory rates were 50.8%, 43.2%, 38.2%, and 55.5%, respectively, under the dose of 2 mg/kg (qd x 10), 2 mg/kg (q2d x 5), 4 mg/kg (qd x 1) and 4 mg/kg (q5d x 2). The inhibitory rate of EAC model was 33.5% under the dose of 4 mg/kg (q5d x 2). The inhibitory rates were significantly higher in test groups than in control groups (P<0.01). rN48 and rK49 had no inhibitory effect on proliferation of the 4 tumor cell lines and on growth of the xenograft tumors. CONCLUSION: The antitumor effect of rSSBPLA(2) may be closely related with its enzymatic activity.

Original languageEnglish (US)
Pages (from-to)1474-1478
Number of pages5
JournalChinese Journal of Cancer
Volume24
Issue number12
StatePublished - Dec 2005
Externally publishedYes

Fingerprint

Elapidae
Phospholipases A2
varespladib methyl
Cell Line
Heterografts
Snake Venoms
Myeloid Leukemia
Snakes
Venoms
Hep G2 Cells
Myeloid Cells
Liver Neoplasms
Growth
Site-Directed Mutagenesis
Tumor Cell Line
Neuroblastoma
Ascites
Sarcoma
Inhibitory Concentration 50
Stomach Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Liang, Y. J., Yang, X. P., Wei, J. W., Fu, L. W., Jiang, X., Chen, S. W., & Yang, W. L. (2005). Correlation of antitumor effect of recombinant sea snake basic phospholipase A2 to its enzymatic activity. Chinese Journal of Cancer, 24(12), 1474-1478.

Correlation of antitumor effect of recombinant sea snake basic phospholipase A2 to its enzymatic activity. / Liang, Yong Ju; Yang, Xiao Ping; Wei, Jian Wen; Fu, Li Wu; Jiang, Xiaoyu; Chen, Shang Wu; Yang, Wen Li.

In: Chinese Journal of Cancer, Vol. 24, No. 12, 12.2005, p. 1474-1478.

Research output: Contribution to journalArticle

Liang, YJ, Yang, XP, Wei, JW, Fu, LW, Jiang, X, Chen, SW & Yang, WL 2005, 'Correlation of antitumor effect of recombinant sea snake basic phospholipase A2 to its enzymatic activity', Chinese Journal of Cancer, vol. 24, no. 12, pp. 1474-1478.
Liang, Yong Ju ; Yang, Xiao Ping ; Wei, Jian Wen ; Fu, Li Wu ; Jiang, Xiaoyu ; Chen, Shang Wu ; Yang, Wen Li. / Correlation of antitumor effect of recombinant sea snake basic phospholipase A2 to its enzymatic activity. In: Chinese Journal of Cancer. 2005 ; Vol. 24, No. 12. pp. 1474-1478.
@article{9ac0e7b1685b4148ba9fd6a04f540623,
title = "Correlation of antitumor effect of recombinant sea snake basic phospholipase A2 to its enzymatic activity",
abstract = "BACKGROUND & OBJECTIVE:Snake venom phospolipase A2 (PLA(2)), a large family of homologous (14 ku) soluble proteins, exerts diverse pharmacologic activities as well as enzymatic activities. So far, the structure and function of terrestrial snake PLA(2), especially the relationship of its enzymatic and pharmacologic activities have been studied extensively, but the investigation of sea snake PLA(2) are limited. This study was to investigate the in vitro and in vivo antitumor effects of recombinant sea snake basic PLA(2) (rSSBPLA(2)) and its mutants rN48 and rK4 from sea snake Lapemis hardwickii venom, and to explore the influence of 2 residues related with the enzymatic activity on the antitumor effects. METHODS: Site-directed mutagenesis of the 2 conserved residues related with enzymatic activity (His48 mutated to Asn and Asp49 mutated to Lys) was performed. The inhibitory effects of rSSBPLA(2), rN48 and rK49 on proliferation of human myeloid leukemia cell line HL-60, human neuroblastoma cell line SK-N-SH, human gastric cancer cell line MGC-803, and human liver cancer cell line HepG2 were assessed by MTT assay. Their antitumor effects on sarcoma cell line S180 xenograft and EAC ascites cancer model in mice were detected. RESULTS: The relative enzymatic activities of rN48 and rK49 were 0 and 5{\%} of that of rSSBPLA(2). The 50{\%} inhibitory concentration (IC(50)) of rSSBPLA(2) for HL60, SK-N-SH, and MGC-803 cells were (45.28+/-0.09) microg/ml, (57.07+/-0.12) microg/ml, and (69.34+/-0.35) microg/ml, respectively, but it had no inhibitory effect on proliferation of HepG2 cells. rSSBPLA(2) obviously inhibited growth of S180 xenograft in mice{\^u} the inhibitory rates were 50.8{\%}, 43.2{\%}, 38.2{\%}, and 55.5{\%}, respectively, under the dose of 2 mg/kg (qd x 10), 2 mg/kg (q2d x 5), 4 mg/kg (qd x 1) and 4 mg/kg (q5d x 2). The inhibitory rate of EAC model was 33.5{\%} under the dose of 4 mg/kg (q5d x 2). The inhibitory rates were significantly higher in test groups than in control groups (P<0.01). rN48 and rK49 had no inhibitory effect on proliferation of the 4 tumor cell lines and on growth of the xenograft tumors. CONCLUSION: The antitumor effect of rSSBPLA(2) may be closely related with its enzymatic activity.",
author = "Liang, {Yong Ju} and Yang, {Xiao Ping} and Wei, {Jian Wen} and Fu, {Li Wu} and Xiaoyu Jiang and Chen, {Shang Wu} and Yang, {Wen Li}",
year = "2005",
month = "12",
language = "English (US)",
volume = "24",
pages = "1474--1478",
journal = "Cancer Communications",
issn = "1000-467X",
publisher = "BioMed Central Ltd.",
number = "12",

}

TY - JOUR

T1 - Correlation of antitumor effect of recombinant sea snake basic phospholipase A2 to its enzymatic activity

AU - Liang, Yong Ju

AU - Yang, Xiao Ping

AU - Wei, Jian Wen

AU - Fu, Li Wu

AU - Jiang, Xiaoyu

AU - Chen, Shang Wu

AU - Yang, Wen Li

PY - 2005/12

Y1 - 2005/12

N2 - BACKGROUND & OBJECTIVE:Snake venom phospolipase A2 (PLA(2)), a large family of homologous (14 ku) soluble proteins, exerts diverse pharmacologic activities as well as enzymatic activities. So far, the structure and function of terrestrial snake PLA(2), especially the relationship of its enzymatic and pharmacologic activities have been studied extensively, but the investigation of sea snake PLA(2) are limited. This study was to investigate the in vitro and in vivo antitumor effects of recombinant sea snake basic PLA(2) (rSSBPLA(2)) and its mutants rN48 and rK4 from sea snake Lapemis hardwickii venom, and to explore the influence of 2 residues related with the enzymatic activity on the antitumor effects. METHODS: Site-directed mutagenesis of the 2 conserved residues related with enzymatic activity (His48 mutated to Asn and Asp49 mutated to Lys) was performed. The inhibitory effects of rSSBPLA(2), rN48 and rK49 on proliferation of human myeloid leukemia cell line HL-60, human neuroblastoma cell line SK-N-SH, human gastric cancer cell line MGC-803, and human liver cancer cell line HepG2 were assessed by MTT assay. Their antitumor effects on sarcoma cell line S180 xenograft and EAC ascites cancer model in mice were detected. RESULTS: The relative enzymatic activities of rN48 and rK49 were 0 and 5% of that of rSSBPLA(2). The 50% inhibitory concentration (IC(50)) of rSSBPLA(2) for HL60, SK-N-SH, and MGC-803 cells were (45.28+/-0.09) microg/ml, (57.07+/-0.12) microg/ml, and (69.34+/-0.35) microg/ml, respectively, but it had no inhibitory effect on proliferation of HepG2 cells. rSSBPLA(2) obviously inhibited growth of S180 xenograft in miceû the inhibitory rates were 50.8%, 43.2%, 38.2%, and 55.5%, respectively, under the dose of 2 mg/kg (qd x 10), 2 mg/kg (q2d x 5), 4 mg/kg (qd x 1) and 4 mg/kg (q5d x 2). The inhibitory rate of EAC model was 33.5% under the dose of 4 mg/kg (q5d x 2). The inhibitory rates were significantly higher in test groups than in control groups (P<0.01). rN48 and rK49 had no inhibitory effect on proliferation of the 4 tumor cell lines and on growth of the xenograft tumors. CONCLUSION: The antitumor effect of rSSBPLA(2) may be closely related with its enzymatic activity.

AB - BACKGROUND & OBJECTIVE:Snake venom phospolipase A2 (PLA(2)), a large family of homologous (14 ku) soluble proteins, exerts diverse pharmacologic activities as well as enzymatic activities. So far, the structure and function of terrestrial snake PLA(2), especially the relationship of its enzymatic and pharmacologic activities have been studied extensively, but the investigation of sea snake PLA(2) are limited. This study was to investigate the in vitro and in vivo antitumor effects of recombinant sea snake basic PLA(2) (rSSBPLA(2)) and its mutants rN48 and rK4 from sea snake Lapemis hardwickii venom, and to explore the influence of 2 residues related with the enzymatic activity on the antitumor effects. METHODS: Site-directed mutagenesis of the 2 conserved residues related with enzymatic activity (His48 mutated to Asn and Asp49 mutated to Lys) was performed. The inhibitory effects of rSSBPLA(2), rN48 and rK49 on proliferation of human myeloid leukemia cell line HL-60, human neuroblastoma cell line SK-N-SH, human gastric cancer cell line MGC-803, and human liver cancer cell line HepG2 were assessed by MTT assay. Their antitumor effects on sarcoma cell line S180 xenograft and EAC ascites cancer model in mice were detected. RESULTS: The relative enzymatic activities of rN48 and rK49 were 0 and 5% of that of rSSBPLA(2). The 50% inhibitory concentration (IC(50)) of rSSBPLA(2) for HL60, SK-N-SH, and MGC-803 cells were (45.28+/-0.09) microg/ml, (57.07+/-0.12) microg/ml, and (69.34+/-0.35) microg/ml, respectively, but it had no inhibitory effect on proliferation of HepG2 cells. rSSBPLA(2) obviously inhibited growth of S180 xenograft in miceû the inhibitory rates were 50.8%, 43.2%, 38.2%, and 55.5%, respectively, under the dose of 2 mg/kg (qd x 10), 2 mg/kg (q2d x 5), 4 mg/kg (qd x 1) and 4 mg/kg (q5d x 2). The inhibitory rate of EAC model was 33.5% under the dose of 4 mg/kg (q5d x 2). The inhibitory rates were significantly higher in test groups than in control groups (P<0.01). rN48 and rK49 had no inhibitory effect on proliferation of the 4 tumor cell lines and on growth of the xenograft tumors. CONCLUSION: The antitumor effect of rSSBPLA(2) may be closely related with its enzymatic activity.

UR - http://www.scopus.com/inward/record.url?scp=34548406598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548406598&partnerID=8YFLogxK

M3 - Article

C2 - 16351795

AN - SCOPUS:34548406598

VL - 24

SP - 1474

EP - 1478

JO - Cancer Communications

JF - Cancer Communications

SN - 1000-467X

IS - 12

ER -